MTT5
Product Specifications
Target
TLR
Applications
Immunology & Inflammation
Additionnal Information
MTT5 is an agonist of TLR7 that activates dendritic cells and CD8+ T cells, enhancing immune responses in the tumor microenvironment. When linked to an ADC, it enhances antitumor efficacy through combined immune stimulation and cytotoxicity.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
R2033-03 200 µL
RBM3, CT (Putative RNA-binding Protein 3, RNA-binding Motif Protein 3, RNPL)
Sign In for Pricing
View Details 